The UN Uyghur report called the situation in Xinjiang an international human rights crime. Who will be first to sue? And why are Vanguard and BlackRock allowed to invest in banned companies?
CPA economist Jeff Ferry talks about IPEF. What should Washington focus on, and what they should outright avoid.
South Korea does not like the Inflation Reduction Act’s special treatment of North American-made EVs. What can Washington do about it?
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
The multilateral trading system, birthed on October 30, 1947, was unceremoniously knifed and left for dead by President Biden’s signing of the Inflation Reduction Act. This is an unprecedented move by the United States in our seventy-five year history as part of that system. Retaliation will come from much of the world. Here is what…
A look at what some senior executives are saying this earnings season about the dollar’s misalignment with the major currencies of the world.
CPA economists Jeff Ferry and Amanda Mayoral explain the continued deterioration of market share for domestic producers versus imports.
CPA tax policy director, David Morse, explains why mostly-domestic companies with over a billion in profits might get a more even playing field with rivals who use profit shifting, offshoring, to pay less taxes.
In a surprise development last night, Senate Majority Leader Chuck Schumer (D, N.Y.) and Senator Joe Manchin (D, W.Va.), with support from President Biden, announced a deal on a massive tax, energy and healthcare legislative package. Sen. Kyrsten Sinema (D-Ariz.), as of the time of this writing, has not indicated her support, and she’s a…
CPA chief economist Jeff Ferry says the CHIPS Act is needed to counter China’s rise in the semiconductor space, and that the R&D component of the bill needs to include guardrails so American academia isn’t beta-testing and researching new chips in partnership with Chinese universities and companies.